Fosså, SD and Kaye, SB and Mead, GM and Cullen, M and de Wit, R and Bodrogi, I and van Groeningen, CJ and De Mulder, PH and Stenning, S and Lallemand, E and De Prijck, L and Collette, L (1998) Filgrastim during combination chemotherapy of patients with poor-prognosis metastatic germ cell malignancy. European Organization for Research and Treatment of Cancer, Genito-Urinary Group, and the Medical Research Council Testicular Cancer Working Party, Cambridge, United Kingdom. J Clin Oncol , 16 (2) 716 - 724.
Full text not available from this repository.
Abstract
To determine the effect of r-metHu granulocyte colony-stimulating factor (G-CSF) on the proportion of patients with metastatic poor-prognosis malignant germ cell tumors who receive full dose-intensity combination chemotherapy.
| Type: | Article |
|---|---|
| Title: | Filgrastim during combination chemotherapy of patients with poor-prognosis metastatic germ cell malignancy. European Organization for Research and Treatment of Cancer, Genito-Urinary Group, and the Medical Research Council Testicular Cancer Working Party, Cambridge, United Kingdom. |
| Location: | UNITED STATES |
| Language: | English |
| Keywords: | Adolescent, Adult, Antineoplastic Combined Chemotherapy Protocols, Bleomycin, Cisplatin, Etoposide, Germinoma, Granulocyte Colony-Stimulating Factor, Humans, Male, Middle Aged, Prognosis, Recombinant Proteins |
| UCL classification: | UCL > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Epidemiology and Health Care > CHIME |
Archive Staff Only: edit this record